Ближайший уровень поддержки по SPY – 191.00 уровень сопротивления – 192.25



SNCR покупка выше 42, ниже продажа

CRR покупка выше 106

SALE при удержании 18 покупка, ниже продажа

AGN следим за акцией

BLMN покупка при удержании 15

Ближайший уровень поддержки по SPY – 192.80 уровень сопротивления – 193.75



PDCE следим за ней, возможен шорт

ALR покупка выше 35

KORS покупка от 76

Gapping up/down: COH and ODP +6% after earnings, MNI, GCI and ACH trading higher on M&A news; BLMN and IHG -4% after earnings, PNRA -2% after CFO resigns

Gapping up 
In reaction to strong earnings/guidance: NLS +12.8%, GTAT +10.4%, AKRX +7%, COH +6.2%, CHGG +6.1%, ODP +5.7%, EPAM +4.4%, CAR +4.2%, JMBA +4.2%, CRZO +4%, TSRA +3.8%, ANV +3.7%, ANSS +3.2%, MWA +3.1%, ELNK +3.1%, ARQL +3.1%, REGI +2.6%, KFRC +2.4%, ARCO +2.3%, AIG +2.1%, WLK +2.1%, MRO +2%, MGM +1.8%, VSI +1.4%, THC +1.3%, CVS +1.3%, KWK +1.1%, BCRX +1%,.

M&A news: MNI +12.7% (announces agreement to sell its 25.6% stake in Cars.com to Gannett (GCI)), GCI +6.4% (MNI announces agreement to sell its 25.6% stake in Cars.com to Gannett (GCI)), AHC +6.2% (A.H. Belo to sell its units in Classified Ventures to Gannett (GCI) for a price that values CV at $2.5 bln; remains Cars.com reseller).

Select solar stocks trading higher: YGE +2.8%, TSL +2.8%, CSIQ +2%, FSLR +1.7%, HSOL +1.1%, SUNE +0.7%, JKS +0.3%.

Other news: BAXS +25% (announces 2 new patents for VEO direct lateral and AxiaLIF minimally invasive interbody fusion systems), USU +8% (disclosed an amendment to its agreement with the Department of Energy that provides for additional funds of ~$5.7 mln), ZNGA +1.8% (still checking), P +1.7% (may launch Talk Radio for cars, according to reports out yesterday afternoon), GRPN +1.3% (still checking), TASR +1.2% (reports orders for hundreds of AXON Cameras for July),.

Analyst comments: HIMX +4.5% (upgraded to Buy from Neutral at BofA/Merrill), SERV +3.5% (initiated with a Overweight at Piper Jaffray), ADHD +2.3% (initiated with a Overweight at Piper Jaffray), FMS +1.8% (upgraded to Buy from Neutral at UBS), THC +1.3% (upgraded to Neutral from Negative at Susquehanna)

Gapping down
In reaction to disappointing earnings/guidance: FIVN -27%, SALE -23.9%, END -12.8%, LF -6.8%, MSI -6.4%, ECOM -5.3%, CTIC -4.8%, BLMN -4.1%, IHG -3.9%, MDR -3.6%, ROSE -3.3%, GTXI -3.3%, SYKE -3.1%, OESX -3%, WAIR -2.7%, ACT -2.6%, CNQR -2.3%, REGN -2.2%, DRC -2%, AREX -1.9%, CNK -1.9%, RHP -1.9%, ALLT -1.8%, PXD -1.5%, TGT -1.3%, ENH -1.2%, HCLP -1%.

M&A news: TEF -0.7% (TEF launches acquisition offer for Vivendi's (VIV) GVT unit), VIV -0.2% (TEF launches acquisition offer for Vivendi's (VIV) GVT unit).

Select EUrelated names showing weakness: ALU -3.5%, DB -2.6%, UBS -1.6%, ARMH -1.1%, BCS -0.9%.

Other news: DRAM -3.1% (pulling back from yesterday's move), STAY -2.2% (announced launch of secondary offering by selling shareholder), PNRA -2% (announced CFO departure; Bill Moreton, Executive Vice Chairman and former CEO, to serve as interim CFO), ESI -1.4% (announced that CEO Kevin M. Modany intends to resign, effective February 4, 2015; John Dean named Executive Chairman; Eugene Feichtner promoted to President and COO), BHP -1.1% (potentially related to weaker than expected Aus Trade Balance), BERY -1% (announced 14,728,218 share secondary public offering by certain funds affiliated with Apollo Global Management).

Ближайший уровень поддержки по SPY – 192.85 уровень сопротивления – 193.10



TMST, LOCO смотрим на покупку недавнее IPO

OCN смотрим на покупку при удержании 27.50

Gapping up/down: KORS +3.3%, HSBC +1.8%, BRK.B +1.5% on earnings, PIKE +47.7% on M&A, Drug/biotech names higher… oil/gas related names lower

Gapping up:
In reaction to strong earnings/guidance: KORS +3.3%, HSBC +1.8%, BRK.B +1.5%.

M&A related: PIKE +47.7% (Pike Shareholders to receive cash of $12.00 per share in transaction led by Court Square Capital Partners), EVR +1.7% (following late weakness — Evercore confirmed plans to to acquire ISI Group and the remaining 40% interest in Evercore's Institutional Equities business; co will issue up to ~ 8 mln share equivalents in the two transactions; transaction expected to be accretive to Adjusted Pro Forma EPS in first year and has potential to be meaningfully accretive starting in 2016), GSK +1% SNY +0.5% (PE firms may purchase older drug brands of GSK and Sanofi (SNY), according to reports),

Drug names/biotech trading higher: TKMR +34.9% (strength attributed to Ebola related fears/plan), LGND +8% (still checking), AZN +0.9% (higher despite reports indicating Hedge funds betting against AZN takeover bid ), ANIP +2.4% (acquires Vancocin capsules and additional vancomycin assets from Shire ), AMGN +1.3% (announces Phase 3 ASPIRE trial of Kyprolis In Patients With Relapsed Multiple Myeloma met primary endpoint; Kyprolis helped patients Live 8.7 months longer without their disease worsening)

Other news: PT +4.8% (traded higher overseas), LOCO +3.9% (still checking), MBLY +3.2% (continued strength/volatility from IPO), DHI +2.9% ( ticking higher on positive Barron's story), INFY +2.8% (traded higher overseas on weaker rupee), EMC +1.2% (Barron's profiles positive view), GPRO +1% (still checking), AAPL +0.8% (still checking), LOGI +0.8% (still checking), SCTY +0.7% (appoints semiconductor veteran Brad Buss as CFO), HLF +0.6% (Barron's report defends name), PSEC +0.6% (exits AirMall at a gross 16.7% internal rate of return and 1.61x cash-on-cash return).

Analyst comments: HIMX +4.3% (upgraded to Buy from Hold at Lake Street), BYI +2.7% (upgraded to Neutral from Sell at Goldman), X +2% ( upgraded to Buy from Hold at Deutsche Bank; upgraded to Buy from Hold at KeyBanc Capital Mkts ), MT +1% (upgraded to Neutral at Exane BNP Paribas), VOD +1% (upgraded to Buy from Neutral at Redburn ), ALU +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), STLD +0.4% (upgraded to Buy from Hold at KeyBanc Capital Mkts), OXY +0.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $120 from $110)

Gapping down:
In reaction to disappointing earnings/guidance: AN -5%, SNH -3.5% (light volume).

Select oil/gas related names showing early weakness: NE -12.2% (downgraded to Hold from Buy at Deutsche Bank), DO -4.9% (downgraded to Sell from Hold at Deutsche Bank), RIG -2.3% (downgraded to Sell from Hold at Deutsche Bank), CVX -0.9%, SDRL -0.9%, CVX -0.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $140 from $135).

Other news: INSM -20.3% (provides regulatory update for ARIKAYCE; Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications; confirms US development plan for NTM Following FDA guidance), ZGNX -7% (announces Departure of Chief Commercial Officer), ARMH -2.2% (still checking), VNR -1.5% (to acquire natural gas, oil and natural gas liquids assets in North Louisiana and East Texas for $278 mln from Hunt Oil; immediately accretive to distributable cash flow at closing, TWTR -1.2% (reports that users do not view ads), CCL -1.2% (still checking), JPM -0.8% (has reached a $4.5 bln mortgage trust related settlement, according to reports), DAN -0.7% ( announces additional $400 million share repurchase authorization, pays dividends on common stock and final dividends on series b convertible preferred stock) QCOR -0.5% ( Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders of Mallinckrodt and Questcor vote for Mallinckrodt's acquisition of Questcor), SODA -0.4% ( Soros liquidated stake, according to reports), MCD -0.3% (to resume full China menu in some cities this week, according to reports).

Analyst comments: DEI -1.2% (downgraded to Sell from Hold at Stifel ), AEP -0.6% (downgraded to Equal Weight from Overweight at Morgan Stanley), RPXC -0.6% (downgraded to Equal Weight from Overweight at Barclays), QLGC -0.2% ( downgraded to Equal Weight from Overweight at Barclays )

Ближайший уровень поддержки по SPY – 195.50 уровень сопротивления – 196.10



X смотрим на продажу

LACI продажа от 70

Описание:
Вебинар посвящен вопросу достижения и закрепления стабильных результатов трейдинга в долгосрочной перспективе. Вы узнаете, какие навыки необходимо развивать трейдеру, без каких рутинных действий не обойтись, от каких привычек нужно избавиться и что предпринимать для ограничения потерь при черных полосах в трейдинге.

Никакой ненужной статистики, только интересные факты из опыта дейтрейдера Ленара Фатихова.

Вебинар будет интересен как начинающим, так и более опытным трейдерам, сталкивающимся с нестабильностью своих результатов. После занятия слушатели будут знать, в какую сторону нужно развивать свою торговую систему для того, чтобы стабилизировать результаты.

План вебинара:
— Как определиться с торговой системой?
— Для чего необходимо все формализовать? 
— Как выходить из черной полосы в трейдинге? 
— Личный риск-менеджмент. 
— Какие качества важно развивать для того, чтобы достичь стабильности в трейдинге?

Особенности вебинара:
Ведущий вебинара — Ленар Фатихов. В дейтрейдинге 4 года. Ежедневное изучение акцийNYSE, NASDAQ, AMEX позволило ему найти свой качественный стиль трейдинга на этих биржах. В конце 2011 года становится Партнером GT Capital Group. На данный момент продолжает заниматься интрадей-трейдингом, а именно – управлением активами, инвестициями, также принимая участие в развитии фирмы